CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|5|572-585

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.5, 2011-06, pp. : 572-585

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hyaluronan Oligomers-HPMA Copolymer Conjugates for Targeting Paclitaxel to CD44-Overexpressing Ovarian Carcinoma

By Journo-Gershfeld Gal   Kapp Dana   Shamay Yosi   Kopeček Jindřich   David Ayelet  

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1121-1133

Springer Publishing Company

Access to resources Recommend Favorite

Hyaluronan: Pharmaceutical Characterization and Drug Delivery

By Liao Yong-Hong   Jones Stuart   Forbes Ben   Martin Gary   Brown Marc  

Drug Delivery, Vol. 12, Iss. 6, 2005-11 ,pp. : 327-342

Informa Healthcare

Access to resources Recommend Favorite

Magnetic Drug Targeting--Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment

By Alexiou Christoph   Jurgons Roland   Schmid Roswitha J.   Bergemann Christian   Henke Julia   Erhardt Wolf   Huenges Ernst   Parak Fritz  

Journal of Drug Targeting, Vol. 11, Iss. 3, 2003-09 ,pp. : 139-149

Informa Healthcare

Access to resources Recommend Favorite

Macromolecular Prodrugs Based on Synthetic Polyaminoacids: Drug Delivery and Drug Targeting in Antitumor Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 18, 2011-09 ,pp. : 2382-2389

Bentham Science Publishers

Access to resources Recommend Favorite

Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment

By  

Current Drug Delivery, Vol. 12, Iss. 2, 2015-04 ,pp. : 177-191

Bentham Science Publishers

Access to resources Recommend Favorite